The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sevoflurane (Sevoflurane Source) Market Research Report 2025
Synopsis
Sevoflurane is a halogenated general inhalation anesthetic drug.
The global Sevoflurane (Sevoflurane Source) market was valued at US$ 1322.6 million in 2023 and is anticipated to reach US$ 1276.4 million by 2030, witnessing a CAGR of -0.5% during the forecast period 2024-2030.
The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue.
This report aims to provide a comprehensive presentation of the global market for Sevoflurane (Sevoflurane Source), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane (Sevoflurane Source).
Report Scope
The Sevoflurane (Sevoflurane Source) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevoflurane (Sevoflurane Source) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane (Sevoflurane Source) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott(AbbVie)
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
For Human
For Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sevoflurane (Sevoflurane Source) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sevoflurane is a halogenated general inhalation anesthetic drug.
The global Sevoflurane (Sevoflurane Source) market was valued at US$ 1322.6 million in 2023 and is anticipated to reach US$ 1276.4 million by 2030, witnessing a CAGR of -0.5% during the forecast period 2024-2030.
The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue.
This report aims to provide a comprehensive presentation of the global market for Sevoflurane (Sevoflurane Source), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane (Sevoflurane Source).
Report Scope
The Sevoflurane (Sevoflurane Source) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sevoflurane (Sevoflurane Source) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sevoflurane (Sevoflurane Source) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott(AbbVie)
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
For Human
For Animal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sevoflurane (Sevoflurane Source) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Sevoflurane (Sevoflurane Source) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 For Human
1.3.3 For Animal
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sevoflurane (Sevoflurane Source) Market Perspective (2019-2030)
2.2 Sevoflurane (Sevoflurane Source) Growth Trends by Region
2.2.1 Global Sevoflurane (Sevoflurane Source) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sevoflurane (Sevoflurane Source) Historic Market Size by Region (2019-2024)
2.2.3 Sevoflurane (Sevoflurane Source) Forecasted Market Size by Region (2025-2030)
2.3 Sevoflurane (Sevoflurane Source) Market Dynamics
2.3.1 Sevoflurane (Sevoflurane Source) Industry Trends
2.3.2 Sevoflurane (Sevoflurane Source) Market Drivers
2.3.3 Sevoflurane (Sevoflurane Source) Market Challenges
2.3.4 Sevoflurane (Sevoflurane Source) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sevoflurane (Sevoflurane Source) Players by Revenue
3.1.1 Global Top Sevoflurane (Sevoflurane Source) Players by Revenue (2019-2024)
3.1.2 Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Players (2019-2024)
3.2 Global Sevoflurane (Sevoflurane Source) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sevoflurane (Sevoflurane Source) Revenue
3.4 Global Sevoflurane (Sevoflurane Source) Market Concentration Ratio
3.4.1 Global Sevoflurane (Sevoflurane Source) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sevoflurane (Sevoflurane Source) Revenue in 2023
3.5 Sevoflurane (Sevoflurane Source) Key Players Head office and Area Served
3.6 Key Players Sevoflurane (Sevoflurane Source) Product Solution and Service
3.7 Date of Enter into Sevoflurane (Sevoflurane Source) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sevoflurane (Sevoflurane Source) Breakdown Data by Type
4.1 Global Sevoflurane (Sevoflurane Source) Historic Market Size by Type (2019-2024)
4.2 Global Sevoflurane (Sevoflurane Source) Forecasted Market Size by Type (2025-2030)
5 Sevoflurane (Sevoflurane Source) Breakdown Data by Application
5.1 Global Sevoflurane (Sevoflurane Source) Historic Market Size by Application (2019-2024)
5.2 Global Sevoflurane (Sevoflurane Source) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sevoflurane (Sevoflurane Source) Market Size (2019-2030)
6.2 North America Sevoflurane (Sevoflurane Source) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sevoflurane (Sevoflurane Source) Market Size by Country (2019-2024)
6.4 North America Sevoflurane (Sevoflurane Source) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sevoflurane (Sevoflurane Source) Market Size (2019-2030)
7.2 Europe Sevoflurane (Sevoflurane Source) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2019-2024)
7.4 Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Size (2019-2030)
8.2 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Size by Region (2019-2024)
8.4 Asia-Pacific Sevoflurane (Sevoflurane Source) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sevoflurane (Sevoflurane Source) Market Size (2019-2030)
9.2 Latin America Sevoflurane (Sevoflurane Source) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sevoflurane (Sevoflurane Source) Market Size by Country (2019-2024)
9.4 Latin America Sevoflurane (Sevoflurane Source) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size (2019-2030)
10.2 Middle East & Africa Sevoflurane (Sevoflurane Source) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2019-2024)
10.4 Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott(AbbVie)
11.1.1 Abbott(AbbVie) Company Detail
11.1.2 Abbott(AbbVie) Business Overview
11.1.3 Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Introduction
11.1.4 Abbott(AbbVie) Revenue in Sevoflurane (Sevoflurane Source) Business (2019-2024)
11.1.5 Abbott(AbbVie) Recent Development
11.2 Baxter
11.2.1 Baxter Company Detail
11.2.2 Baxter Business Overview
11.2.3 Baxter Sevoflurane (Sevoflurane Source) Introduction
11.2.4 Baxter Revenue in Sevoflurane (Sevoflurane Source) Business (2019-2024)
11.2.5 Baxter Recent Development
11.3 Maruishi Pharmaceutical
11.3.1 Maruishi Pharmaceutical Company Detail
11.3.2 Maruishi Pharmaceutical Business Overview
11.3.3 Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Introduction
11.3.4 Maruishi Pharmaceutical Revenue in Sevoflurane (Sevoflurane Source) Business (2019-2024)
11.3.5 Maruishi Pharmaceutical Recent Development
11.4 Jiangsu Hengrui
11.4.1 Jiangsu Hengrui Company Detail
11.4.2 Jiangsu Hengrui Business Overview
11.4.3 Jiangsu Hengrui Sevoflurane (Sevoflurane Source) Introduction
11.4.4 Jiangsu Hengrui Revenue in Sevoflurane (Sevoflurane Source) Business (2019-2024)
11.4.5 Jiangsu Hengrui Recent Development
11.5 Lunan
11.5.1 Lunan Company Detail
11.5.2 Lunan Business Overview
11.5.3 Lunan Sevoflurane (Sevoflurane Source) Introduction
11.5.4 Lunan Revenue in Sevoflurane (Sevoflurane Source) Business (2019-2024)
11.5.5 Lunan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
